IL-21, Inflammatory Cytokines and Hyperpolarized CD8 + T Cells Are Central Players in Lupus Immune Pathology.
Soumya SenguptaGargee BhattacharyaSubhasmita MohantyShubham K ShawGajendra M JogdandRohila JhaPrakash K BarikJyoti R ParidaSatish DevadasPublished in: Antioxidants (Basel, Switzerland) (2023)
Systemic lupus erythematous (SLE) is a chronic autoimmune disorder, broadly characterized by systemic inflammation along with heterogeneous clinical manifestations, severe morbidity, moribund organ failure and eventual mortality. In our study, SLE patients displayed a higher percentage of activated, inflamed and hyper-polarized CD8 + T cells, dysregulated CD8 + T cell differentiation, significantly elevated serum inflammatory cytokines and higher accumulation of cellular ROS when compared to healthy controls. Importantly, these hyper-inflammatory/hyper-polarized CD8 + T cells responded better to an antioxidant than to an oxidant. Terminally differentiated Tc1 cells also showed plasticity upon oxidant/antioxidant treatment, but that was in contrast to the SLE CD8 + T cell response. Our studies suggest that the differential phenotype and redox response of SLE CD8 + T cells and Tc1 cells could be attributed to their cytokine environs during their respective differentiation and eventual activation environs. The polarization of Tc1 cells with IL-21 drove hyper-cytotoxicity without hyper-polarisation suggesting that the SLE inflammatory cytokine environment could drive the extreme aberrancy in SLE CD8 + T cells.
Keyphrases
- systemic lupus erythematosus
- disease activity
- induced apoptosis
- cell cycle arrest
- oxidative stress
- rheumatoid arthritis
- anti inflammatory
- magnetic resonance
- end stage renal disease
- endoplasmic reticulum stress
- dna damage
- magnetic resonance imaging
- risk factors
- multiple sclerosis
- newly diagnosed
- signaling pathway
- type diabetes
- coronary artery disease
- pi k akt
- cardiovascular events
- peritoneal dialysis
- drug induced
- smoking cessation
- combination therapy